7-26178021-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004289.7(NFE2L3):āc.649G>Cā(p.Ala217Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000737 in 1,614,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004289.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NFE2L3 | NM_004289.7 | c.649G>C | p.Ala217Pro | missense_variant | 2/4 | ENST00000056233.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NFE2L3 | ENST00000056233.4 | c.649G>C | p.Ala217Pro | missense_variant | 2/4 | 1 | NM_004289.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251460Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135910
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461806Hom.: 0 Cov.: 30 AF XY: 0.0000261 AC XY: 19AN XY: 727210
GnomAD4 genome AF: 0.000440 AC: 67AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000456 AC XY: 34AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.649G>C (p.A217P) alteration is located in exon 2 (coding exon 2) of the NFE2L3 gene. This alteration results from a G to C substitution at nucleotide position 649, causing the alanine (A) at amino acid position 217 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at